Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...
GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The GSK-Oxford Cancer Immuno ...
A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...
GSK has teamed up with the University of Oxford on a programme that will try to identify the molecular changes in cells in precancerous stages that could form the basis of vaccines to prevent full ...
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore the potential of cancer prevention through vaccination. The partnership ...
Sciences Division at the University of Oxford, will replace Dr. Jesse Goodman, who retires following nine years of service. Dr. Screaton brings to GSK extensive expertise in immunology and ...
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines. The University of Oxford and GSK are to work on a vaccine to target cells in the ...
Collaboration unites GSK and Oxford’s complementary expertise in the science of the immune system, vaccines and cancer biology GSK to invest up to £50 million in collaboration to generate key insights ...
Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback